Inhaled Nitric Oxide Treatment of Patients with Pulmonary Tuberculosis Evidenced by Positive Sputum Smears
AUTOR(ES)
Long, Richard
FONTE
American Society for Microbiology
RESUMO
Endogenous nitric oxide (NO) has antimycobacterial properties. We tested the hypothesis that exogenous (inhaled) NO can be safely delivered and can accelerate airway disinfection for pulmonary tuberculosis patients treated with standard therapy. Exogenous NO administered at 80 ppm for 72 h can be safely delivered but does not accelerate airway disinfection.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=549277Documentos Relacionados
- Inhaled nitric oxide for the treatment of persistent pulmonary hypertension.
- Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients.
- Inhaled nitric oxide for pulmonary hypertension after repair of exomphalos.
- Equipment review: Pulmonary uptake and modes of administration of inhaled nitric oxide in mechanically-ventilated patients
- Enumeration of Tubercle Bacilli in Sputum of Patients with Pulmonary Tuberculosis
